Reporter Archive — Page 564 of 662

December 19, 2013

VU study identifies new gene fusions in melanoma

Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer.

December 18, 2013

VUMC positioned to meet challenges ahead: Balser

“The downsizing effort is over.” With those words, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the School of Medicine, announced Wednesday that workforce reduction efforts announced in September at Vanderbilt University Medical Center are completed.

December 18, 2013

Targeting tumor “supply lines”

A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies.

December 16, 2013

Cancer drug enhances cognition

The breast cancer drug tamoxifen improves cognitive performance in post-menopausal women.

December 13, 2013

Manager of mitotic stress

The protein CK1 delays cell division to avoid the generation of defects that drive tumorigenesis.

December 12, 2013

Study to explore new technologies to connect doctors, patients outside medical settings

A five-year study to explore new technologies that automate patient care outside of hospitals and doctors’ offices will identify ways technology can provide real-time feedback and guidance to patients and to alert care coordination teams before health issues escalate.